We are live on ! Find out more
PACB icon

Pacific Biosciences
PACB

155 hedge funds and large institutions have $809M invested in Pacific Biosciences in 2018 Q4 according to their latest regulatory filings, with 71 funds opening new positions, 45 increasing their positions, 25 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

109% more first-time investments, than exits

New positions opened: 71 | Existing positions closed: 34

89% more call options, than puts

Call options by funds: $8.75M | Put options by funds: $4.62M

80% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 25

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

37% more capital invested

Capital invested by funds: $590M → $809M (+$220M)

31% more funds holding

Funds holding: 118 → 155 (+37)

1.4% less ownership

Funds ownership: 74.5% → 73.1% (-1.4%)

Holders
155
Holders Change
+37
Holders Change %
+31.36%
% of All Funds
3.45%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
71
Increased
45
Reduced
25
Closed
34
Calls
$8.75M
Puts
$4.62M
Net Calls
+$4.12M
Net Calls Change
+$4.54M

Top Buyers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
+$58.8M
2
AA
AQR Arbitrage
Connecticut
+$41.7M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$28.2M
4
AAM
Alpine Associates Management
Florida
+$27M
5
UOC
UBS O'Connor
Illinois
+$19M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$70.1M
2
MC
Maverick Capital
Texas
-$65.9M
3
AIM
ARK Investment Management
Florida
-$49.3M
4
OIM
Oracle Investment Management
Connecticut
-$43.3M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$28M
Name Holding Trade Value Shares
Change 		Change in
Stake
Canada Pension Plan Investment Board
26
Canada Pension Plan Investment Board
Ontario, Canada
$10M +$8.6M +1,357,200 New
SAM
27
Stansberry Asset Management
Texas
$8.07M +$6.91M +1,091,124 New
FCM
28
Frontier Capital Management
Massachusetts
$7.74M -$2.11M -333,113 -24%
VI
29
Versor Investments
New York
$7.51M +$6.43M +1,014,432 New
EMPI
30
Elo Mutual Pension Insurance
Finland
$5.85M +$5.01M +790,000 New
IA
31
IndexIQ Advisors
New York
$5.83M +$4.99M +787,469 New
Charles Schwab
32
Charles Schwab
California
$5.57M +$497K +78,493 +12%
OAM
33
Oxford Asset Management
United Kingdom
$4.79M +$3.61M +569,253 +727%
HA
34
Havens Advisors
New York
$4.63M +$3.97M +626,000 New
Bank of New York Mellon
35
Bank of New York Mellon
New York
$4.59M +$469K +74,002 +14%
Marshall Wace
36
Marshall Wace
United Kingdom
$4.59M +$3.93M +620,001 New
Capstone Investment Advisors
37
Capstone Investment Advisors
New York
$4.57M +$3.91M +617,892 New
Barclays
38
Barclays
United Kingdom
$4.43M +$2.82M +444,528 +289%
FTCM
39
First Trust Capital Management
Illinois
$3.92M +$3.36M +529,876 New
Deutsche Bank
40
Deutsche Bank
Germany
$3.81M +$306K +48,353 +10%
GCIA
41
Gabelli & Co Investment Advisers
New York
$3.62M +$3.1M +489,050 New
OP
42
Omni Partners
United Kingdom
$3.61M +$3.09M +487,307 New
Wellington Management Group
43
Wellington Management Group
Massachusetts
$3.46M +$2.96M +466,812 New
Allianz Asset Management
44
Allianz Asset Management
Germany
$3.41M +$2.92M +461,225 New
AllianceBernstein
45
AllianceBernstein
Tennessee
$3.31M +$1.94M +306,157 +218%
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$3.27M – – –
O
47
OppenheimerFunds
New York
$2.76M +$2.36M +372,675 New
Ohio Public Employees Retirement System (OPERS)
48
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.75M +$2.36M +372,000 New
BLAM
49
Bourne Lent Asset Management
New York
$2.48M +$53.9K +8,500 +3%
SCM
50
Stevens Capital Management
Pennsylvania
$2.48M +$2.12M +334,603 New
1
2
3 4 5

PACB Hedge Fund Activity: Q4 2018 in Review

155 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Pacific Biosciences (PACB) for Q4 2018, worth a combined $809M — up 37% from $590M a quarter earlier.

Buyers outnumbered sellers: 71 funds opened new PACB positions and 34 closed out — a net gain of 37 holders — while 45 added to existing stakes and 25 trimmed.

The largest buyer was Magnetar Financial, opening a new position worth an estimated $58.8M. The largest seller was Consonance Capital Management, cutting an estimated $70.1M.

  • 155 institutional investors held Pacific Biosciences (PACB) as of Q4 2018, up from 118 in Q3 2018.
  • Funds reported $809M of Pacific Biosciences stock for Q4 2018, up 37% quarter-over-quarter.
  • 71 funds opened new Pacific Biosciences positions in Q4 2018 and 34 closed out, a net change of +37 holders.
  • The largest Pacific Biosciences buyer in Q4 2018 was Magnetar Financial, an estimated $58.8M added.
  • The largest Pacific Biosciences seller in Q4 2018 was Consonance Capital Management, an estimated $70.1M sold.

Based on aggregated 13F filings for Q4 2018.